(Q44266822)

1 December 2017

title

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam (English)

1 reference

1 December 2017

main subject

Acinetobacter baumannii

1 reference

hospital-acquired infection

inferred from title

1 reference

1

1 reference

1 December 2017

Carlos E Levy

2

1 reference

1 December 2017

A Edison I Manrique

series ordinal

3

1 reference

1 December 2017

Eduardo A S Medeiros

series ordinal

4

1 reference

1 December 2017

Silvia F Costa

series ordinal

5

1 reference

1 December 2017

language of work or name

1 reference

1 January 2003

1 reference

International Journal of Antimicrobial Agents

1 December 2017

published in

1 reference

1 December 2017

volume

21

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

58-62

1 reference

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Beta-lactamase inhibitors and Acinetobacter spp

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

CDC definitions for nosocomial infections, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Outer-membrane proteins pattern and detection of β-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900276-5

7 January 2021

10.1016/S0924-8579(02)00276-5

Identifiers

DOI

1 reference

1 December 2017

1 reference